3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
72
NIH
10
INDUSTRY
3
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Lymphoma
50
Breast Neoplasms
39
Leukemia
33
Precursor Cell Lymphoblastic Leukemia-Lymphoma
25
Multiple Myeloma
19
Neuroblastoma
18
Burkitt Lymphoma
17
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma, Follicular
12
Sarcoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Leukemia, Biphenotypic, Acute
10
Hodgkin Disease
10
Central Nervous System Neoplasms
9
Rhabdomyosarcoma
8
Medulloblastoma
8
Brain Neoplasms
7
Wilms Tumor
6
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Inflammatory Breast Neoplasms
5
Waldenstrom Macroglobulinemia
4
Ovarian Neoplasms
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Malignant mesenchymal tumor
4
Ganglioneuroblastoma
4
Dendritic Cell Sarcoma, Interdigitating
4
Interventions
Specimen Handling
2
Methods
2
Educational Status
2
Early Intervention, Educational
2
trihexyltetradecylphosphonium chloride
1
letermovir
1
gamma-Globulins
1
Voriconazole
1
Vincristine
1
Vaccination
1
Sirolimus
1
Prednisone
1
Pharmacogenomic Testing
1
Patient Navigation
1
Organizational Objectives
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone Acetate
1
Methylprednisolone
1
Lenalidomide
1
Interviews as Topic
1
Infliximab
1
Immunoglobulins, Intravenous
1
Immunoglobulins
1
Health Promotion
1
Fluconazole
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Caspofungin
1
Carvedilol
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Hematologic Neoplasms
×
Cyclophosphamide
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled